Overview

Effectivity and Safety of Combination Cream of Salicylic Acid,Aqua Posae Filiformis,Niacinamide,Lipohydroxy Acid,Procerad,and Zinc PCA

Status:
Recruiting

Trial end date:
2022-12-31

Target enrollment:

Participant gender:

Summary

This clinical study will compare the effectivity and safety of combination cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad, and Zinc PCA as adjuvant therapy for acne vulgaris patients. These combination cream will be tested by mild to moderate acne vulgaris patients. Participants will be female patients aged 15-50 years old and divided into three groups. The control group (Group 1) will use Adapalene 0.1% cream only every night. Group 2 will use Adapalene 0.1% cream intermittently every two nights and the combination cream every morning. Group 3 will use Adapalene 0.1% cream every night and the combination cream every morning.

Phase:

Phase 1

Details

Lead Sponsor:

Dr.dr.Irma Bernadette, SpKK (K)

Treatments:

Adapalene